Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?

Rheumatology

Volumn 47, Issue 6, 2008, Pages 926-927

  Cimmino, M A ^a   Zampogna, G ^a   Parodi, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; FLUORODEOXYGLUCOSE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

BLOOD VESSEL BIOPSY; BONE PAIN; CLINICAL FEATURE; COMORBIDITY; DRUG DOSE REDUCTION; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEVER; GIANT CELL ARTERITIS; HUMAN; IMAGE ANALYSIS; LETTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERY; WEIGHT REDUCTION;

AGED; DRUG RESISTANCE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOCORTICOIDS; HUMANS; POLYMYALGIA RHEUMATICA; POSITRON-EMISSION TOMOGRAPHY; VASCULITIS;

EID: 44849123209     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken098     Document Type: Letter

References (5)

1. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients. Rheumatology 2007;46:672-7.
2. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study in 35 patients. Arthritis Rheum 2006;55:131-7.
3. Mahr AD, Jover JA, Spiera RF et al. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis. Arthritis Rheum 2007;56: 2789-97.
4. Salvarani C, Cantini F, Niccoli L et al. Treatment of refractory polymyalgia rheumatica with infliximab: A pilot study. J Rheumatol 2003;30:760-3.
5. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.